FDA NDC Directory · JSON-LD · Markdown

Pomalyst

NDC 59572-503 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namepomalidomide
Labeler / ManufacturerCelgene Corporation
Marketing categoryNew Drug Application (innovator) · App NDA204026
Dosage form / routeCAPSULE · ORAL
Active ingredientsPOMALIDOMIDE (3 mg/1)
Marketing started20130218
Package count2

External sources

Source: openFDA. Public-domain (CC0).